Clinical Trials

Colorectal Neoplasms

NCT06807437 2026-03-31

Lanreotide Versus Placebo Before Surgery to Prevent a Surgical Complication Called a Pancreatic Fistula

274 enrolled

Pancreatic Neoplasms

NCT07018869 2026-03-31

Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors

1,057 enrolled

Colorectal Neoplasms

NCT02437851 2026-03-30

Surgery in Treating Patients With Early Stage Anal Canal or Perianal Cancer and HIV Infection

16 enrolled

Anal Canal Carcinoma, Anus Neoplasms, HIV Infections

NCT06998940 2026-03-27

Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations

94 enrolled

Pancreatic Neoplasms

NCT04166318 2026-03-23

Lower-Dose Chemoradiation in Treating Patients With Early-Stage Anal Cancer, the DECREASE Study

252 enrolled

Anal Canal Carcinoma, Anus Neoplasms

NCT04233866 2026-03-23

Comparing Two Treatment Combinations, Gemcitabine and Nab-Paclitaxel With 5-Fluorouracil, Leucovorin, and Liposomal Irinotecan for Older Patients With Pancreatic Cancer That Has Spread

176 enrolled

Phase NA Active not recruiting

Pancreatic Neoplasms

NCT04239573 2026-03-23

Comparing Two Methods to Follow Patients With Pancreatic Cysts

4,606 enrolled

Phase 3 Active not recruiting

Pancreatic Neoplasms

NCT04248452 2026-03-23

Testing the Addition of Radiotherapy to the Usual Treatment (Chemotherapy) for Patients With Esophageal and Gastric Cancer That Has Spread to a Limited Number of Other Places in the Body

314 enrolled

Adenocarcinoma Of Esophagus

NCT05863195 2026-03-23

Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial

408 enrolled

Phase 2/3 Active not recruiting

Colorectal Neoplasms

NCT04559139 2026-03-19

Comparison of Chemotherapy Before and After Surgery Versus After Surgery Alone for the Treatment of Gallbladder Cancer

186 enrolled

CNSDermatologicGastrointestinalGenitourinaryGynecologicLymphoidSarcoma

Gallbladder Neoplasms

NCT04851119 2026-02-24

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

Phase 1/2 Recruiting

147 enrolled

Carcinoma, Hepatocellular, Lymphoma, Non-Hodgkin, Melanoma, Wilms Tumor, Neuroblastoma, Ovarian Neoplasms, Sarcoma, Ewing, Osteosarcoma, Colorectal Neoplasms, Endometrial Neoplasms, Hepatoblastoma, Desmoid Tumors

NCT06620302 2026-02-24

Testing the Addition of an Anti-cancer Drug, DT2216, to the Usual Chemotherapy Treatment for Relapsed or Refractory Solid Tumors and Fibrolamellar Carcinoma

Phase 1/2 Recruiting

81 enrolled

Fibrolamellar hepatocellular carcinoma

NCT03365882 2026-02-10

S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery

240 enrolled 14 charts

Colonic Neoplasms, Rectal Neoplasms

NCT01730937 2026-01-28

Sorafenib Tosylate With or Without Stereotactic Body Radiation Therapy in Treating Patients With Liver Cancer

Phase 3 Completed

193 enrolled 29 charts

Carcinoma, Hepatocellular

NCT06976710 2026-01-22

PC2

564 enrolled

Colorectal Neoplasms

NCT03768414 2026-01-12

Gemcitabine Hydrochloride and Cisplatin With or Without Nab-Paclitaxel in Treating Patients With Newly Diagnosed Advanced Biliary Tract Cancers

Phase 3 Completed

452 enrolled 17 charts

Phase 3 Active not recruiting

Gallbladder Neoplasms, Cholangiocarcinoma

NCT03533582 2025-12-22

Cisplatin and Combination Chemotherapy in Treating Children and Young Adults With Hepatoblastoma or Liver Cancer After Surgery

537 enrolled

Fibrolamellar hepatocellular carcinoma, Hepatoblastoma

NCT05694936 2025-09-18

Combining Sodium Valproate With Standard-of-care EGFR (Epidermal Growth Factor Receptor) Monoclonal Antibody Treatment in Patients With Metastatic Colorectal Cancer

90 enrolled

Phase NA Active not recruiting

Colorectal Neoplasms

NCT00819208 2025-09-16

CHALLENGE

889 enrolled

Phase NA Active not recruiting

Anxiety Disorders, Colonic Neoplasms, Depression, Fatigue, Sleep Wake Disorders, Colorectal Neoplasms

NCT03822572 2025-09-10

ABCSG C08

92 enrolled

Colorectal Neoplasms

NCT02598349 2025-09-09

Proton Radiation for Unresectable, Borderline Resectable, or Medically Inoperable Carcinoma of the Pancreas

60 enrolled

Pancreatic Neoplasms

NCT03499808 2025-09-09

S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis

GastrointestinalOtherPlasma cell

43 enrolled 23 charts

Lymphadenopathy, Immunoglobulin Light-chain Amyloidosis, Constipation, Diarrhea, Gastrointestinal Hemorrhage, Hepatomegaly, Macroglossia, Nausea, Purpura

NCT06462963 2025-08-01

SPRINT

BreastGastrointestinalGenitourinary

302 enrolled

Breast Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms

NCT02205047 2025-07-31

INNOVATION

172 enrolled

Stomach Neoplasms

NCT06441747 2025-07-29

Phase II Study of the Combination of Durvalumab (MEDI4736) (PDL1 Inhibitor) and Olaparib (PARP Inhibitor) in Advanced Cholangiocarcinoma After Initial Chemotherapy and Durvalumab (BIL-PPP)

40 enrolled

Cholangiocarcinoma

NCT06290505 2025-07-23

PALEO

54 enrolled

Phase 2 Not yet recruiting

Esophageal Neoplasms

NCT07058012 2025-07-10

EMPIRE

79 enrolled

Colonic Neoplasms

NCT03153280 2025-07-08

Lithium

Phase 1 Terminated

2 enrolled

Esophageal Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

NCT06149546 2025-07-08

FEED

70 enrolled

Phase 1 Not yet recruiting

Pancreatic Neoplasms

NCT06978062 2025-06-05

NeoBEMA

27 enrolled

GastroEsophageal Cancer

NCT00324415 2025-05-30

Combined Modality Therapy for Patients With With HIV and Stage I, Stage II, or Stage III Anal Cancer

45 enrolled 17 charts

Phase NA Not yet recruiting

Anal Canal Carcinoma, Anus Neoplasms

NCT06938490 2025-04-22

COLAP-D3

778 enrolled

Phase 4 Enrolling by invitation

Neoplasms, Colorectal Neoplasms, Anastomotic Leak

NCT06931808 2025-04-17

Intestinal Microbiota Transplantation, Radiochemotherapy and Sintilimab in Localized Advanced Colon Cancer

20 enrolled

Phase 2/3 Active not recruiting

Localized Advanced Rectal Adenocarcinoma

NCT01924819 2025-03-04

TOPGEAR

574 enrolled

Phase 3 Not yet recruiting

Stomach Neoplasms

NCT06845306 2025-02-25

ICG-NIRF

1,268 enrolled

Colonic Neoplasms

NCT06094140 2024-12-03

NEO-IMPACT

20 enrolled

Pancreatic Neoplasms

NCT02511522 2024-10-23

Study of Palliative Radiotherapy for Symptomatic Hepatocellular Carcinoma and Liver Metastases

Phase NA Completed

66 enrolled 9 charts

Carcinoma, Hepatocellular

NCT05042128 2024-10-22

ASCEND

158 enrolled

Pancreatic Neoplasms

NCT04498767 2024-08-26

OligoRARE

DermatologicGastrointestinalGenitourinaryHead & NeckSarcoma

200 enrolled

Urinary Bladder Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Kidney Neoplasms, Melanoma, Pancreatic Neoplasms, Sarcoma, Skin Neoplasms, Stomach Neoplasms

NCT02135419 2024-07-26

ANCHOR

Phase 3 Completed

4,446 enrolled 13 charts

GastrointestinalGynecologic

Squamous Intraepithelial Lesions, Acquired Immunodeficiency Syndrome, Anus Neoplasms, HIV Infections, Papillomavirus Infections

NCT01941316 2024-05-09

Study of Carfilzomib With Irinotecan in Irinotecan-Sensitive Malignancies and Small Cell Lung Cancer Patients

Phase 1/2 Completed

78 enrolled 15 charts

GastrointestinalGynecologicThoracic

Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Esophageal Neoplasms, Ovarian Neoplasms, Stomach Neoplasms, Small Cell Lung Carcinoma

NCT04205955 2024-05-01

Testing Diet Intervention Versus Non-Diet Intervention for Management of Bowel Symptoms in Rectal Cancer Survivors

95 enrolled 30 charts